Literature DB >> 2824266

Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

P Arner1, T Pollare, H Lithell, J N Livingston.   

Abstract

The tyrosine kinase activity of the insulin receptor was investigated in skeletal muscle biopsies from insulin-resistant males with obesity or with Type 2 (non-insulin-dependent) diabetic males who were lean or overweight. The kinase activity of the receptor from all three groups of insulin-resistant subjects was 40% less when compared to the activity of lean control subjects. This alteration was present in the absence of changes in the level of the insulin receptor on its insulin binding characteristics. We conclude that the tyrosine kinase activity of the skeletal muscle insulin receptor is defective in obesity and Type 2 diabetes, and that this alteration contributes to the insulin-resistant characteristics of both disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824266     DOI: 10.1007/BF00292549

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Purification of the insulin receptor from human placenta by chromatography on immobilized wheat germ lectin and receptor antibody.

Authors:  L C Harrison; A Itin
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

Review 2.  The molecular mechanism of insulin action.

Authors:  C R Kahn
Journal:  Annu Rev Med       Date:  1985       Impact factor: 13.739

3.  Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity.

Authors:  J F Caro; O Ittoop; W J Pories; D Meelheim; E G Flickinger; F Thomas; M Jenquin; J F Silverman; P G Khazanie; M K Sinha
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases.

Authors:  S Braun; W E Raymond; E Racker
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

5.  Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.

Authors:  G R Freidenberg; R R Henry; H H Klein; D R Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  Complete analysis of cellular nucleotides by two-dimensional thin layer chromatography.

Authors:  B R Bochner; B N Ames
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

7.  Alterations in the tyrosine kinase activity of the insulin receptor produced by in vitro hyperinsulinemia.

Authors:  G Arsenis; J N Livingston
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

8.  Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men.

Authors:  J Bolinder; H Lithell; E Skarfors; P Arner
Journal:  Diabetes       Date:  1986-03       Impact factor: 9.461

9.  Studies of the human liver insulin receptor in noninsulin-dependent diabetes mellitus.

Authors:  P Arner; K Einarsson; S Ewerth; J Livingston
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

10.  Studies of liver insulin receptors in non-obese and obese human subjects.

Authors:  P Arner; K Einarsson; L Backman; K Nilsell; K M Lerea; J N Livingston
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

  10 in total
  53 in total

Review 1.  Insulin signaling defects in type 2 diabetes.

Authors:  Ying Leng; Håkan K R Karlsson; Juleen R Zierath
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  Insulin resistance of glucose metabolism in isolated brown adipocytes of lactating rats. Evidence for a post-receptor defect in insulin action.

Authors:  A F Burnol; S Ebner; J Kandé; J Girard
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

3.  Activation of liver and muscle insulin receptor tyrosine kinase activity during in vivo insulin administration in rats.

Authors:  Y T Kruszynska; P A Halban; C R Kahn; M F White
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

Review 4.  Role of kinases in insulin stimulation of glucose transport.

Authors:  A Klip; A G Douen
Journal:  J Membr Biol       Date:  1989-10       Impact factor: 1.843

5.  Association of the insulin receptor and phosphatidylinositol 3-kinase requires a third component.

Authors:  R Liu; J N Livingston
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

6.  Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes.

Authors:  L Mosthaf; J Eriksson; H U Häring; L Groop; E Widen; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered.

Authors:  M Kellerer; M Coghlan; E Capp; A Mühlhöfer; G Kroder; L Mosthaf; P Galante; K Siddle; H U Häring
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Regulation of human insulin receptor RNA splicing in vivo.

Authors:  S Norgren; J Zierath; A Wedell; H Wallberg-Henriksson; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 9.  Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Felber; E Haesler; E Jéquier
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

10.  Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients.

Authors:  H A Koistinen; A V Chibalin; J R Zierath
Journal:  Diabetologia       Date:  2003-08-23       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.